Compare Raymond James Financial, Inc. (RJF) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Raymond James Financial, Inc. vs Teladoc Health Inc — how do they compare? Raymond James Financial, Inc. trades at $175.47 (market cap $33.75B), while Teladoc Health Inc trades at $6.09 (market cap $1.11B). The key difference: Raymond James Financial, Inc. is far larger — about 30.4× Teladoc Health Inc's market cap, and Raymond James Financial, Inc. pays a 1.23% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| RJF | TDOC | |
|---|---|---|
Market Cap | $33.75B | $1.11B |
Sector | Financials | Health |
52-Week High | $181.18 | $9.72 |
52-Week Low | $140.89 | $4.47 |
Dividend Yield | 1.23% | — |
Enterprise Value | — | $1.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Raymond James Financial (RJF) trades at $176.55, down 0.98% on the day, with a mixed technical picture showing bearish overall signals but bullish moving averages. The company demonstrates strong fundamental performance with consistent earnings beats, including Q2 2026 EPS of $3.14 beating estimates of $2.93, and revenue growth from $10.9B in 2022 to $13.84B in 2025. Recent developments include dividend declarations and PGA TOUR sponsorship announcements.
RJF presents a balanced investment case with 44% analyst buy ratings and a $184.11 consensus price target offering 4.3% upside. Strengths include consistent earnings growth and wealth management expansion, while risks involve rising expenses and capital market volatility. The stock trades at reasonable valuations with P/E of 15.39 and P/S of 2.36, supported by 15.37% net margins.
TDOC trades at $6.26, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $200.32 million in 2025, though revenue remains stable at $2.53 billion. Analyst consensus is a hold with a $8.88 price target, while recent news highlights leadership changes and ongoing legal investigations.
The outlook is cautious; while valuation ratios like P/S of 0.45 and EV/EBITDA of 6.5 appear attractive, persistent losses and negative ROE of -12.99% pose risks. Upside depends on profitability improvements under new CFO Michael Grasher, but investor sentiment is tempered by weak earnings and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
